Renaissance Technologies’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.3M | Sell |
|
|||||
|
2025
Q1 | $16.4M | Sell |
|
|||||
|
2024
Q4 | $18.5M | Sell |
|
|||||
|
2024
Q3 | $18.8M | Sell |
|
|||||
|
2024
Q2 | $23.2M | Sell |
|
|||||
|
2024
Q1 | $17.6M | Buy |
|
|||||
|
2023
Q4 | $15.5M | Buy |
|
|||||
|
2023
Q3 | $14.1M | Buy |
|
|||||
|
2023
Q2 | $20.5M | Buy |
|
|||||
|
2023
Q1 | $19.9M | Buy |
|
|||||
|
2022
Q4 | $21.4M | Sell |
|
|||||
|
2022
Q3 | $32.6M | Sell |
|
|||||
|
2022
Q2 | $39.6M | Buy |
|
|||||
|
2022
Q1 | $36.3M | Sell |
|
|||||
|
2021
Q4 | $50.4M | Sell |
|
|||||
|
2021
Q3 | $56.3M | Sell |
|
|||||
|
2021
Q2 | $71.2M | Sell |
|
|||||
|
2021
Q1 | $55.4M | Sell |
|
|||||
|
2020
Q4 | $52.4M | Sell |
|
|||||
|
2020
Q3 | $42.3M | Buy |
|
|||||
|
2020
Q2 | $48.4M | Buy |
|
|||||
|
2020
Q1 | $39.9M | Buy |
|
|||||
|
2019
Q4 | $56.7M | Buy |
|
|||||
|
2019
Q3 | $42.6M | Buy |
|
|||||
|
2019
Q2 | $39.4M | Buy |
|
|||||
|
2019
Q1 | $47.2M | Buy |
|
|||||
|
2018
Q4 | $65.6M | Buy |
|
|||||
|
2018
Q3 | $47M | Buy |
|
|||||
|
2018
Q2 | $32M | Buy |
|
|||||
|
2018
Q1 | $27.6M | Buy |
|
|||||
|
2017
Q4 | $21.8M | Buy |
|
|||||
|
2017
Q3 | $21.8M | Buy |
|
|||||
|
2017
Q2 | $17.9M | Buy |
|
|||||
|
2017
Q1 | $13.2M | Buy |
|
|||||
|
2016
Q4 | $9.06M | Buy |
|
|||||
|
2016
Q3 | $7.19M | Buy |
|
|||||
|
2016
Q2 | $1.69M | Sell |
|
|||||
|
2016
Q1 | $3.48M | Buy |
|
|||||
|
2015
Q4 | $3.14M | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $1.81M | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $2.81M | Sell |
|
|||||
|
2013
Q2 | $2.86M | Buy |
|